Genpharmasec Ltd — Important, 11-11-2025: Company Update

Genpharmasec has submitted its financial results for the quarter and half-year ending September 30, 2025. For the quarter, standalone revenue from operations was 31.56 Cr with a profit of 0.82 Cr. Consolidated revenue stood at 32.64 Cr, reporting a net loss of 1.18 Cr. For the half-year, standalone revenue reached 43.68 Cr with a profit of 2.38 Cr, while consolidated revenue was 44.08 Cr, showing a net profit of 0.04 Cr. The company completed the 70% stake acquisition of Derren Healthcare Private Limited in July, impacting consolidated figures. It also reclassified certain equity shares as long-term investments.